ArticleUltrasonics2025
Low-intensity therapeutic ultrasound effects on intracellular sodium and reactive oxygen species in ex vivo human islets for control of insulin release.
Article in Ultrasonics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Ultrasound has shown potential to non-invasively stimulate insulin release from pancreatic β-cells, but the underlying mechanisms remain poorly understood. Prior studies have suggested that mechanical effects from ultrasound, such as membrane deformation and cavitation, may play a role in modulating ion channel activity and insulin secretion. However, direct observations of intracellular signaling responses in human islets during ultrasound application are limited. In this work we investigate the effects of ultrasound on human islets in vitro using confocal fluorescence microscopy and enzyme-linked immunosorbent assay (ELISA) to measure intracellular sodium and reactive oxygen species (ROS). Human islets obtained through the NIDDK Integrated Islet Distribution Program (IIDP) were treated with ultrasound, and high glucose. Ultrasound was applied using an 800 kHz unfocused transducer for 3 min at 0.5 W/cm
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.